Dorsey & Whitney Trust’s Amedisys AMED Stock Holding History

Dorsey & Whitney Trust’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,624	Closed	-$203K	–	377
2018 Q3	$203K	Buy	+1,624	New	+$179K	0.03%	391

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dorsey & Whitney Trust's AMED Position: Q4 2018 in Review

Dorsey & Whitney Trust sold out of Amedisys (AMED) in Q4 2018, closing a stake of 1,624 shares — an estimated $203K sold.

Dorsey & Whitney Trust first reported a position in AMED in Q3 2018 and held it in 1 quarter. The position peaked at $203K in Q3 2018. 297 funds tracked by Wall St. Rank hold AMED as of Q4 2018.

Dorsey & Whitney Trust reported no remaining Amedisys position as of Q4 2018 after selling out during the quarter.
Dorsey & Whitney Trust sold 1,624 Amedisys shares in Q4 2018, an estimated $203K.
Dorsey & Whitney Trust first reported a position in Amedisys in Q3 2018 and held it in 1 quarter.
Dorsey & Whitney Trust's Amedisys position peaked at $203K in Q3 2018.
297 funds tracked by Wall St. Rank held Amedisys as of Q4 2018.

Based on Dorsey & Whitney Trust's 13F filing for Q4 2018, filed 25 Jan 2019.